• Updated
  • 0
  • 6 min to read

On Monday, Eli Lilly announced it has begun studying an experimental drug that has been derived from a blood sample of an individual that survived COVID-19.

Get up-to-the-minute news sent straight to your device.

Topics

Arts

BeerBuzz

Education

Entertainment

Environment

Food

Music

Opinion

Society & Individual